Quibim Launches CE and UKCA-Marked QP-Breast®, the First AI Tool to Detect Breast Cancer via MRI in Europe and the UK
- Published
- Source
- AZOrobotics.com
Quibim, a prominent player in precision imaging and artificial intelligence solutions, has launched QP-Breast® in Europe and the UK. This innovative AI tool, which has received CE and UKCA marking, is the first of its kind in these regions to utilize magnetic resonance imaging for the detection of breast cancer. By automatically identifying suspected lesions on breast MRI scans, QP-Breast® aims to enhance early diagnosis and improve patient outcomes. The launch, announced today, marks a significant advancement in breast cancer detection technology, reflecting Quibim's commitment to leveraging AI for better healthcare solutions.
Original report
Quibim Launches CE and UKCA-Marked QP-Breast®, the First AI Tool to Detect Breast Cancer via MRI in Europe and the UK
AZOrobotics.comThis briefing is an independently written summary based on publicly available reporting and is provided for industry information and news discovery. The original report and source publication are credited and linked where applicable. RobotToday does not claim ownership of third-party source material.
Rights concerns? Contact [email protected] with the relevant URL and details. We will review the matter and take appropriate action where warranted.
Robotics needs a service framework.
RSF defines a common language for robot service capability, lifecycle operations, certification pathways, and service-provider networks.
Join the RobotToday community on LinkedIn
Daily robotics news, in-depth analysis, conference highlights, and discussions with professionals worldwide.
